Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 1/2024

25-10-2022 | Endoprosthesis | Original Article

Prognostic Factors Influencing Survival and Oncological Outcome in Patients with Parosteal Osteosarcoma

Authors: Buğra Alpan, Osman Emre Aycan, Serkan Bayram, Emre Özmen, Natig Valiyev, Harzem Özger, Levent Eralp

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2024

Login to get access

Abstract

This study aimed to evaluate the significance of radiological (magnetic resonance imaging [MRI]) findings, surgical, and previous interventions on prognosis with oncological and functional outcome in patients with parosteal osteosarcoma (POS). Twenty-seven patients (8 male/19 female) who were operated with the diagnosis of primary POS in our institution were retrospectively reviewed. The epidemiological data, biopsy method, misdiagnosis/improper interventions, and delay in diagnosis were noted. The lesions’ maximum circumferential extension, maximum longitudinal extension, intramedullary involvement, and neurovascular extensions in MRI sections were evaluated, and the resection type (segmental intraarticular/segmental intercalary/hemicortical), reconstruction type (biologic/non-biologic), and surgical margins were noted. Functional and oncological results at the last follow-up were assessed. The mean age was 31.6 (12–73) years, and mean follow-up was 80.8 (24–270) months. Intramedullary involvement percentage was related with maximum circumferential extension percentage and maximum longitudinal extension. (p = 0.006, p = 0.005) The intramedullary involvement ratio of ≤ 10% suggested no recurrence or metastasis. The neurovascular encasement was related to metastatic disease, deep infections, and complication related surgeries (p = 0.017, p = 0.002, p = 0.005). The most common resection type was segmental intraarticular resection (63%). The maximum circumferential extension percentage, the maximum longitudinal extension of the lesion, intramedullary involvement percentage, and neurovascular encasement had lower MSTS scores (p = 0.003, p = 0.028, p = 0.038, p = 0.022). The mean MSTS score was 81.1% (60–100%). The 5-year overall survival was 96.3%, local recurrence-free survival was 77.2%, and metastasis-free survival was 69.4%. The lesions’ extent of intramedullary involvement, neurovascular bundle proximity, and maximum periosteal circumferential extension on MRI should be considered when planning the surgery.
Literature
1.
go back to reference Bertoni F, Bacchini P, Staals EL, Davidovitz P (2005) Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer 103(11):2373–2382CrossRefPubMed Bertoni F, Bacchini P, Staals EL, Davidovitz P (2005) Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer 103(11):2373–2382CrossRefPubMed
2.
go back to reference Campanacci M, Picci P, Gherlinzoni F, Guerra A, Bertoni F, Neff JR (1984) Parosteal osteosarcoma. J Bone Joint Surg Br 66(3):313–321CrossRefPubMed Campanacci M, Picci P, Gherlinzoni F, Guerra A, Bertoni F, Neff JR (1984) Parosteal osteosarcoma. J Bone Joint Surg Br 66(3):313–321CrossRefPubMed
3.
go back to reference Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK (1994) Parosteal osteosarcoma A clinicopathological study. J Bone Joint Surg Am 76(3):366–378CrossRefPubMed Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK (1994) Parosteal osteosarcoma A clinicopathological study. J Bone Joint Surg Am 76(3):366–378CrossRefPubMed
4.
go back to reference Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, Sumathi V, Grimer R (2015) The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J 97-B(12):1698–1703CrossRefPubMed Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, Sumathi V, Grimer R (2015) The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J 97-B(12):1698–1703CrossRefPubMed
6.
go back to reference Hoshi M, Matsumoto S, Manabe J, Tanizawa T, Shigemitsu T, Izawa N, Shi X, Kawaguchi N (2006) Oncologic outcome of parosteal osteosarcoma. Int J Clin Oncol 11(2):120–126CrossRefPubMed Hoshi M, Matsumoto S, Manabe J, Tanizawa T, Shigemitsu T, Izawa N, Shi X, Kawaguchi N (2006) Oncologic outcome of parosteal osteosarcoma. Int J Clin Oncol 11(2):120–126CrossRefPubMed
7.
go back to reference Funovics PT, Bucher F, Toma CD, Kotz RI, Dominkus M (2011) Treatment and outcome of parosteal osteosarcoma: biological versus endoprosthetic reconstruction. J Surg Oncol 103(8):782–789CrossRefPubMed Funovics PT, Bucher F, Toma CD, Kotz RI, Dominkus M (2011) Treatment and outcome of parosteal osteosarcoma: biological versus endoprosthetic reconstruction. J Surg Oncol 103(8):782–789CrossRefPubMed
8.
go back to reference Ben Brahim E, Sebai MA, Mbarki S, Tangour M, Bouzaïdi K, Ben Romdhane K, Tebib M, Chatti S (2009) Femoral parosteal osteosarcoma 18 years after its discovery: a case report. Orthop Traumatol Surg Res 95(4):305–358CrossRefPubMed Ben Brahim E, Sebai MA, Mbarki S, Tangour M, Bouzaïdi K, Ben Romdhane K, Tebib M, Chatti S (2009) Femoral parosteal osteosarcoma 18 years after its discovery: a case report. Orthop Traumatol Surg Res 95(4):305–358CrossRefPubMed
9.
go back to reference Combalia A, Muñoz-Mahamud E, Palacín A, Pomés J, López V (2011) Local recurrence of a parosteal osteosarcoma 21 years after incomplete resection. Chin J Cancer 30(12):861–866 CrossRefPubMedPubMedCentral Combalia A, Muñoz-Mahamud E, Palacín A, Pomés J, López V (2011) Local recurrence of a parosteal osteosarcoma 21 years after incomplete resection. Chin J Cancer 30(12):861–866 CrossRefPubMedPubMedCentral
10.
go back to reference Johnson K, Davies AM, Evans N, Grimer RJ (2001) Imaging recurrent parosteal osteosarcoma. Eur Radiol 11(3):460–466CrossRefPubMed Johnson K, Davies AM, Evans N, Grimer RJ (2001) Imaging recurrent parosteal osteosarcoma. Eur Radiol 11(3):460–466CrossRefPubMed
11.
go back to reference Jelinek JS, Murphey MD, Kransdorf MJ, Shmookler BM, Malawer MM, Hur RC (1966) Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade. Radiol 201(3):837–842CrossRef Jelinek JS, Murphey MD, Kransdorf MJ, Shmookler BM, Malawer MM, Hur RC (1966) Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade. Radiol 201(3):837–842CrossRef
12.
go back to reference Lewis VO, Gebhardt MC, Springfield DS (2000) Parosteal osteosarcoma of the posterior aspect of the distal part of the femur Oncological and functional results following a new resection technique. J Bone Joint Surg Am 82-B(8):1083–1088CrossRef Lewis VO, Gebhardt MC, Springfield DS (2000) Parosteal osteosarcoma of the posterior aspect of the distal part of the femur Oncological and functional results following a new resection technique. J Bone Joint Surg Am 82-B(8):1083–1088CrossRef
13.
go back to reference Liu T, Liu ZY, Zhang Q, Zhang XS (2013) Hemicortical resection and reconstruction using pasteurised autograft for parosteal osteosarcoma of the distal femur. Bone Joint J 95-B(9):1275–1179CrossRefPubMed Liu T, Liu ZY, Zhang Q, Zhang XS (2013) Hemicortical resection and reconstruction using pasteurised autograft for parosteal osteosarcoma of the distal femur. Bone Joint J 95-B(9):1275–1179CrossRefPubMed
14.
go back to reference Han I, Oh JH, Na YG, Moon KC, Kim HS (2008) Clinical outcome of parosteal osteosarcoma. J Surg Oncol 97(2):146–149CrossRefPubMed Han I, Oh JH, Na YG, Moon KC, Kim HS (2008) Clinical outcome of parosteal osteosarcoma. J Surg Oncol 97(2):146–149CrossRefPubMed
15.
go back to reference Ahuja SC, Villacin AB, Smith J, Bullough PG, Huvos AG, Marcove RC (1977) Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis. J Bone Joint Surg Am 59(5):632–647CrossRefPubMed Ahuja SC, Villacin AB, Smith J, Bullough PG, Huvos AG, Marcove RC (1977) Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis. J Bone Joint Surg Am 59(5):632–647CrossRefPubMed
16.
go back to reference Deijkers RL, Bloem RM, Hogendoorn PC, Verlaan JJ, Kroon HM, Taminiau AH (2002) Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours. J Bone Joint Surg Br 84(7):1009–1014CrossRefPubMed Deijkers RL, Bloem RM, Hogendoorn PC, Verlaan JJ, Kroon HM, Taminiau AH (2002) Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours. J Bone Joint Surg Br 84(7):1009–1014CrossRefPubMed
17.
go back to reference Agarwal M, Puri A, Anchan C, Shah M, Jambhekar N (2007) Hemicortical excision for low-grade selected surface sarcomas of bone. Clin Orthop Relat Res 459:161–166CrossRefPubMed Agarwal M, Puri A, Anchan C, Shah M, Jambhekar N (2007) Hemicortical excision for low-grade selected surface sarcomas of bone. Clin Orthop Relat Res 459:161–166CrossRefPubMed
Metadata
Title
Prognostic Factors Influencing Survival and Oncological Outcome in Patients with Parosteal Osteosarcoma
Authors
Buğra Alpan
Osman Emre Aycan
Serkan Bayram
Emre Özmen
Natig Valiyev
Harzem Özger
Levent Eralp
Publication date
25-10-2022
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue Special Issue 1/2024
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-022-01670-z

Other articles of this Special Issue 1/2024

Indian Journal of Surgical Oncology 1/2024 Go to the issue